HomeNewsBusinessReal EstateResidential sales in Los Angeles above $10m soar despite COVID-19 pandemic 
Trending Topics

Residential sales in Los Angeles above $10m soar despite COVID-19 pandemic 

Knight Frank forecasts further prime price increases of 3% in 2021 due to a shortage of quality stock, a result of the post pandemic-induced surge in sales.

May 19, 2021 / 15:47 IST
Story continues below Advertisement

Despite the COVID-19 pandemic, Los Angeles witnessed a significant increase in the number of residential sales above $10m in 2020, up 26 percent compared to a year earlier, according to Knight Frank.

One hundred and fifty five properties at this level transacted in the market over the year, overshadowing the 123 registered in 2019.

Story continues below Advertisement

Despite the strong sales rates, the average sale price in LA dipped from $20m to $17m over the same period. However, prime price growth remains strong with the market experiencing an 8 percent increase in prime prices in 2020, making it the 10th consecutive year of price growth.

Knight Frank forecasts further prime price increases of 3 percent in 2021 due to a shortage of quality stock, a result of the post pandemic-induced surge in sales.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show